Microbiota / Microbiome

I. Identification of microbiota patterns

Characteristic of CRC, BC and LC tumours compared to other unaffected areas of the tumour and to the microbiota of individuals without tumours.

II. Identify microorganisms

Associated with the different histological subtypes of the three types of tumours.

III. To analyse changes in the microbiota

Associated with the expression levels of genes responsible for immune escape phenomena, tumour response, tumour suppression and cell cycle control.

IV. To analyse the role of metabolites

Produced by the microbiota in the tumour response.

Microbiome Characterisation

Liquid, tissue and stool biopsy

  • Prospective selection of patients, recruitment and follow-up of patients, sample collection and collection of clinical and anthropometric data.
  • Processing of tissue, blood and stool samples.
  • Analysis of the bacterial profile of tissue, stool and blood samples and assessment of histological response.
  • Analysis of the microbiota at baseline, during and after treatment.
  • Analysis of gene expression in patients and its relationship with the bacterial profile.
  • Determination of short-chain fatty acids, bile acids and polyamines.
  • Analysis of the results of the microbiome (association between microbiota, tumour expression profile and response to treatment).
Icono del Cáncer de mama
Breast cancer
Icono del Cáncer colorrectal
Colorectal cancer
Icono del Cáncer de pulmón
Lung cancer